ArticleFrontiers in oncology2022

Treatment plan prescreening for patient-specific quality assurance measurements using independent Monte Carlo dose calculations.

Yuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.